Please assess the completion status of the following clinical trial:

Trial Title: A Web-based Platform to Conduct Trials of mHealth Apps for Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* age over 18~* diagnosis of hypertension~* interested in using an app for hypertension management~* access to a smartphone with internet connection~* access to a blood pressure monitoring device (in home or community setting, e.g., pharmacy)~Exclusion Criteria:~* participant-reported BP within target within the 2 weeks prior to enrolment. Target range for patients with diabetes is systolic BP \<130 mm Hg and diastolic BP \< 80 mm Hg; for those without diabetes, target range is systolic BP \<140 mm Hg and diastolic BP \< 90 mm Hg according to Hypertension Canada guidelines~* emergent hypertensive concerns with systolic BP ≥180 mmHg or diastolic BP ≥120 within the 2 weeks prior to enrolment~* current use of a mobile app for hypertension management~* pregnancy~* not living in Canada~* unwillingness or inability to give informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intervention App Group (Type: EXPERIMENTAL): The intervention group will be instructed to download the chosen hypertension mobile health app (Sphygmo BP) via a link provided on the platform. The hypertension app has blood pressure tracking and monitoring features and they are instructed to use the app. They will also receive a link to the Heart and Stroke foundation website which includes information on hypertension management and measuring blood pressure.
- Educational Control Group (Type: NO_INTERVENTION): The control will comprise usual care including any anti-hypertensive medication and lifestyle changes, and the link to the Heart and Stroke Foundation website which includes information on hypertension management and measuring blood pressure.

Based on this trial design, predict the completion outcome and termination type (if applicable).